August 4, 2025

Nuvalent, Inc. (NUVL) Stock Analysis: Biotechnology Innovator with 50.85% Potential Upside

Nuvalent, Inc. (NASDAQ: NUVL) is catching the attention of investors with its promising potential in the biotechnology sector. With a market capitalization of $5.58 billion, this clinical-stage biopharmaceutical company is..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Exploring a 18.95% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the medical devices industry, is currently drawing attention from investors with its healthcare innovations and a notable potential upside of..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Healthcare Innovator with 18% Upside Potential

TransMedics Group, Inc. (NASDAQ: TMDX), a trailblazer in the healthcare sector, is capturing the attention of investors with its cutting-edge medical devices that are transforming organ transplant therapies. With a..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring the 40.84% Potential Upside for Investors

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a dynamic player in the biotechnology sector, is commanding attention with its potential for substantial returns. With a market capitalization of $6.71 billion, this U.S.-based..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 23.10% Potential Upside with Strong Buy Ratings

Merit Medical Systems, Inc. (NASDAQ: MMSI) stands out in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $5.02 billion, this Utah-based company..

Legend Biotech Corporation (LEGN) Stock Analysis: Unraveling the 96.62% Potential Upside in Biotech Innovation

Legend Biotech Corporation (NASDAQ: LEGN) is making waves in the biotechnology sector with its promising pipeline of innovative therapies and a substantial market capitalization of $7.14 billion. As a key..

Charles River Laboratories (CRL) Stock Analysis: Navigating Challenges in the Healthcare Sector

Charles River Laboratories International, Inc. (NYSE: CRL), a prominent player in the healthcare sector’s Diagnostics & Research industry, faces a mixed landscape as it navigates current market conditions. With a..

Cytokinetics, Inc. (CYTK) Stock Analysis: Biotech Potential with 96.53% Upside

Cytokinetics, Incorporated (NASDAQ: CYTK), a biopharmaceutical innovator headquartered in South San Francisco, California, is making waves in the healthcare sector with its groundbreaking focus on muscle activators and inhibitors. As..

Akero Therapeutics (AKRO) Stock Analysis: 57.74% Potential Upside Captivates Investors

Akero Therapeutics, Inc. (NASDAQ: AKRO), a promising player in the biotechnology sector, is capturing investor attention with a substantial potential upside of 57.74%. Specializing in the development of treatments for..

Corcept Therapeutics (CORT): Uncovering a 94.93% Upside Potential in Biotechnology

Corcept Therapeutics Incorporated (CORT) stands out in the biotechnology sector with a compelling investment narrative, driven by its innovative drug development pipeline and significant upside potential. As a U.S.-based company..

BrightSpring Health Services, I (BTSG) Stock Analysis: An Impressive 43.41% Potential Upside for Investors

BrightSpring Health Services, Inc. (BTSG) is catching the eye of investors with its robust growth potential. Operating in the healthcare sector, specifically within the Health Information Services industry, BrightSpring is..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a 5.27% Potential Upside in the Health Information Services Sector

Veeva Systems Inc. (NYSE: VEEV) stands as a prominent player in the healthcare sector, specifically within the health information services industry. With a robust market capitalization of $45.98 billion, the..

Soleno Therapeutics, Inc. (SLNO) Investor Outlook: Exploring the 33% Upside Potential in Biotech

Soleno Therapeutics, Inc. (NASDAQ: SLNO) has caught the attention of investors recently, not just for its promising therapeutic developments but also for its notable potential upside. With analyst ratings revealing..

Grifols, S.A. (GRFS) Stock Analysis: Unveiling a 13% Upside Potential for Investors

Grifols, S.A. (GRFS), a renowned name in the healthcare sector, stands as a significant player in the drug manufacturing industry, with a robust market capitalization of $9.01 billion. Headquartered in..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a 31.6% Potential Upside in the Healthcare Sector

For investors keen on the healthcare sector, The Cooper Companies, Inc. (NYSE: COO) presents an intriguing opportunity. With a market capitalization of $14.14 billion, this U.S.-based company operates in the..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Volatile Waters of TCM Innovation

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a healthcare company operating out of Hong Kong, is making waves in the niche market of Traditional Chinese Medicine (TCM). With a market cap..

Sarepta Therapeutics, Inc. (SRPT): Navigating Biotech Challenges and Opportunities with Significant 39% Potential Upside

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology sector, remains a focal point for investors seeking exposure to the niche market of RNA-targeted therapeutics and gene therapies. As..

AptarGroup, Inc. (ATR) Stock Analysis: Uncovering a 23.69% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR) is an intriguing player in the healthcare sector, particularly within the medical instruments & supplies industry. With a market capitalization of approximately $9.33 billion, this Illinois-based..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Compelling 67% Potential Upside for Healthcare Investors

Inspire Medical Systems, Inc. (INSP) has captured the attention of investors in the healthcare sector, particularly those with an interest in innovative medical technologies. Headquartered in Golden Valley, Minnesota, Inspire..

Guardant Health, Inc. (GH) Stock Analysis: Exploring a 47% Upside Potential in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH) has emerged as a significant player in the precision oncology sector, leveraging its innovative blood and tissue tests to redefine cancer diagnostics. With a market..

Search

Funds

August 4, 2025

Search

Funds

August 4, 2025

FTSE 100

Funds